Lv0
0 积分 2022-10-26 加入
Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer
1小时前
待确认
CXCR2, a novel target to overcome tyrosine kinase inhibitor resistance in chronic myelogenous leukemia cells
25天前
已完结
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
25天前
已完结
Structural basis of CXC chemokine receptor 2 activation and signalling
25天前
已完结
CCL2 activates NLRP3 inflammasomes to regulate microglial phenotype transformation to promote central sensitisation in chronic migraine
26天前
已完结
Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer
26天前
已完结
Efficacy and Safety of CE-224,535, an Antagonist of P2X7Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate
27天前
已完结
Development of Antibody and Nanobody Tools for P2X7
28天前
已关闭
Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays
1个月前
已完结
Nav1.7 is essential for nociceptor action potentials in the mouse in a manner independent of endogenous opioids
1个月前
已完结
皖公网安备34019202002308
